» Articles » PMID: 27121185

Affect School and Script Analysis Versus Basic Body Awareness Therapy in the Treatment of Psychological Symptoms in Patients with Diabetes and High HbA1c Concentrations: Two Study Protocols for Two Randomized Controlled Trials

Overview
Journal Trials
Publisher Biomed Central
Date 2016 Apr 29
PMID 27121185
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Depression is linked with alexithymia, anxiety, high HbA1c concentrations, disturbances of cortisol secretion, increased prevalence of diabetes complications and all-cause mortality. The psycho-educational method 'affect school with script analysis' and the mind-body therapy 'basic body awareness treatment' will be trialled in patients with diabetes, high HbA1c concentrations and psychological symptoms. The primary outcome measure is change in symptoms of depression. Secondary outcome measures are changes in HbA1c concentrations, midnight salivary cortisol concentration, symptoms of alexithymia, anxiety, self-image measures, use of antidepressants, incidence of diabetes complications and mortality.

Methods: Two studies will be performed. Study I is an open-labeled parallel-group study with a two-arm randomized controlled trial design. Patients are randomized to either affect school with script analysis or to basic body awareness treatment. According to power calculations, 64 persons are required in each intervention arm at the last follow-up session. Patients with type 1 or type 2 diabetes were recruited from one hospital diabetes outpatient clinic in 2009. The trial will be completed in 2016. Study II is a multicentre open-labeled parallel-group three-arm randomized controlled trial. Patients will be randomized to affect school with script analysis, to basic body awareness treatment, or to treatment as usual. Power calculations show that 70 persons are required in each arm at the last follow-up session. Patients with type 2 diabetes will be recruited from primary care. This study will start in 2016 and finish in 2023. For both studies, the inclusion criteria are: HbA1c concentration ≥62.5 mmol/mol; depression, alexithymia, anxiety or a negative self-image; age 18-59 years; and diabetes duration ≥1 year. The exclusion criteria are pregnancy, severe comorbidities, cognitive deficiencies or inadequate Swedish. Depression, anxiety, alexithymia and self-image are assessed using self-report instruments. HbA1c concentration, midnight salivary cortisol concentration, blood pressure, serum lipid concentrations and anthropometrics are measured. Data are collected from computerized medical records and the Swedish national diabetes and causes of death registers.

Discussion: Whether the "affect school with script analysis" will reduce psychological symptoms, increase emotional awareness and improve diabetes related factors will be tried, and compared to "basic body awareness treatment" and treatment as usual.

Trial Registration: ClinicalTrials.gov: NCT01714986.

Citing Articles

Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study.

Melin E, Dereke J, Hillman M BMC Psychiatry. 2020; 20(1):574.

PMID: 33261587 PMC: 7709277. DOI: 10.1186/s12888-020-02977-3.


The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review.

Martino G, Caputo A, Vicario C, Catalano A, Schwarz P, Quattropani M Front Psychol. 2020; 11:2026.

PMID: 32982843 PMC: 7484475. DOI: 10.3389/fpsyg.2020.02026.


Body-Centered Interventions for Psychopathological Conditions: A Review.

Tarsha M, Park S, Tortora S Front Psychol. 2020; 10:2907.

PMID: 32038351 PMC: 6993757. DOI: 10.3389/fpsyg.2019.02907.


Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: a cross sectional study.

Melin E, Thulesius H, Hillman M, Svensson R, Landin-Olsson M, Thunander M Lipids Health Dis. 2019; 18(1):65.

PMID: 30885233 PMC: 6421645. DOI: 10.1186/s12944-019-1009-4.


Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes.

Melin E, Dereke J, Thunander M, Hillman M Endocr Connect. 2018; 7(12):1343-1353.

PMID: 30400063 PMC: 6280594. DOI: 10.1530/EC-18-0336.


References
1.
Fisher L, Gonzalez J, Polonsky W . The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014; 31(7):764-72. PMC: 4065190. DOI: 10.1111/dme.12428. View

2.
Chesler B . Emotional eating: a virtually untreated risk factor for outcome following bariatric surgery. ScientificWorldJournal. 2012; 2012():365961. PMC: 3330752. DOI: 10.1100/2012/365961. View

3.
de Groot M, Anderson R, Freedland K, Clouse R, Lustman P . Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001; 63(4):619-30. DOI: 10.1097/00006842-200107000-00015. View

4.
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati F, Powe N . Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004; 141(6):421-31. DOI: 10.7326/0003-4819-141-6-200409210-00007. View

5.
Lundh L, Torestad B, Bagby R, Taylor G, Parker J . A Swedish translation of the 20-item Toronto Alexithymia Scale: cross-validation of the factor structure. Scand J Psychol. 2000; 41(1):25-30. DOI: 10.1111/1467-9450.00167. View